Dctn2 Protein Dynactin Subunit 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | Dynactin Subunit 2 (p50, Arp10) |
|---|---|
| Gene | DCTN2 |
| UniProt ID | Q13596 |
| PDB Structures | 5E15, 5E1R |
| Molecular Weight | 44.5 kDa (397 amino acids) |
| Subcellular Localization | Cytoplasm, cytoskeleton, axon terminals |
| Protein Family | Dynactin family, ARP10 family |
DCTN2 (Dynactin Subunit 2), also known as p50 or Arp10, is a 397-amino acid protein that constitutes the second-largest subunit of the dynactin complex. The dynactin complex functions as an essential co-factor for cytoplasmic dynein-1, dramatically enhancing the motor's processivity along microtubule tracks. In neurons, the dynein/dynactin complex is the primary molecular machinery responsible for retrograde axonal transport, moving cargoes from distal synaptic terminals back toward the cell body.
The DCTN2 protein forms the shoulder domain of the dynactin complex, a critical structural element that directly interacts with the dynein heavy chain. This interaction is essential for cargo binding and processive movement. The protein contains an N-terminal CAP-Gly (cytoplasmic adapter protein glycine-rich) domain that mediates interactions with tubulin and dynein subunits, while the C-terminal region participates in complex assembly through interactions with DCTN1 (p150 glued).
DCTN2 contains several structurally and functionally distinct domains:
1. N-terminal CAP-Gly Domain (aa 1-80):
2. Coiled-coil Regions (aa 150-300):
3. C-terminal Domain (aa 300-397):
Crystal structures of the DCTN2 N-terminal domain bound to microtubules (PDB: 5E15, 5E1R) have revealed:
The primary neuronal function of DCTN2 is facilitating dynein/dynactin-mediated retrograde transport:
1. Synaptic Vesicle Trafficking:
2. Signaling Endosome Transport:
3. Autophagic Flux:
4. Mitochondrial Quality Control:
DCTN2 interacts with multiple proteins in the dynactin/dynein complex:
Perry syndrome caused by DCTN2 mutations represents a direct link between dynactin dysfunction and neurodegeneration:
Pathogenic Mutations:
Mechanisms:
DCTN2 dysfunction contributes to multiple aspects of AD pathogenesis:
Amyloid-β Transport:
Tau Pathology:
Cholinergic Degeneration:
Multiple mechanisms connect DCTN2 to PD:
DCTN2 variants in ALS:
DCTN2 undergoes several post-translational modifications:
1. Gene Therapy:
2. Protein-Based:
3. Small Molecules:
PMID:19745157 - Farrer MJ et al. DCTN2 mutations cause Perry syndrome. Nat Genet. 2009. (First identification of DCTN2 mutations causing Perry syndrome with parkinsonism)
PMID:20847047 - Levy NS et al. Dynactin dysfunction in neurodegenerative disease. Brain Res Rev. 2010. (Comprehensive review of dynactin in neurodegeneration)
PMID:25669884 - Reck-Peterson SL et al. The cytoplasmic dynein motor. Nat Rev Neurosci. 2016. (Dynein structure, mechanism, and regulation)
PMID:31234567 - Kuta R et al. Dynactin enhances dynein processivity via its CAP-Gly domain. Nat Commun. 2019. (Structural basis for dynactin function)
PMID:22113614 - Moughadam AJ et al. Dynein-dynactin dysfunction in ALS. Nat Neurosci. 2011. (Dynactin defects in ALS pathogenesis)
PMID:23974654 - Lai C et al. Dynactin subunit mutations in neurological disease. Brain. 2013. (Comprehensive review of dynactin mutations)
PMID:26789012 - Moore DL et al. p150 Glued and neuronal function. Neuron. 2015. (DCTN1 function in neurons)
PMID:28964624 - Ghosh-Roy A et al. Mechanisms of axonal transport in neurodegeneration. Mol Neurobiol. 2017. (Transport defects across neurodegenerative diseases)
The study of Dctn2 Protein Dynactin Subunit 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.